Step up to Health, Nigeria! Impact of World Cancer Day Walk on Health Behaviors Among Nigerians
NCT ID: NCT04248881
Last Updated: 2020-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
527 participants
INTERVENTIONAL
2020-02-01
2020-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Step up to Health, Nigeria! Impact of 2022 World Cancer Day Walk on Health Behaviors Among Nigerians
NCT05239325
Walking Affecting Immunology and Quality of Life of Breast Cancer Patients
NCT02581956
A Study With Health Educational Material on Health Promotion in Cancer Survivors
NCT00948337
Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors
NCT01450020
Nurse-Led Quality of Life Study-Phase I
NCT05853614
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Nigeria is the most populous black nation in the world with a population of over 196 million, more than 500 ethnic groups, 380 languages, and a diverse range of cultural, traditional and religious beliefs. Nigeria constitutes approximately 20% of the population of Africa and slightly more than 50% of the West African population. Cancer is a critical public health problem in this population. Nigeria is a major contributor to the overall cancer burden on the continent with 72,000 cancer deaths in 2012 and 115,950 new cases of cancer and 70,327 cancer deaths in 2018. Nigerians also have one of the world's poorest 5-year cancer survival rates.
Breast cancer is the most frequently diagnosed cancer in Nigerian women and the leading cause of cancer death in Nigeria, with an estimated 26,310 new cases and 11,564 deaths in 2018 (44% death rate). Breast cancer incidence in this population historically has been low but is now increasing. By comparison, in the United States (population 329 million) there were 30,700 new breast cancer cases and 6,310 deaths in 2016. Another female cancer - cervical, is 99% preventable, however, it is the second leading cause of cancer death in Nigeria with over 26 deaths every day. By comparison, in the United States between 2013-2017, the average annual death rate of cervical cancer was 2.3% per 100,000 (age adjusted to the 2000 US standard population). Prostate cancer is the leading cause of cancer deaths in Nigerian men with 13,078 new cases (which is 29.1%) and 5,806 deaths in 2018. The age-standardized incidence rates (ASR) for prostate cancer was 32.8 new cases per 100,000 men and mortality rate was about 16.3 per 100,000 men in 2018. On a daily basis, at least 15 men die of prostate cancer in Nigeria. By comparison, in the United States prostate cancer death rates in men declined 52% from 1993 to 2017.
Strategies for prevention and early detection are imperative in the reduction of cancer death rates globally; awareness campaigns (such as the annual "World Cancer Day Walk" in Abuja) are critical to educate the general population on cancer risk factors, the benefits of screening and early detection, and to offer free cancer screening to all populations.
This study "Step up to Health, Nigeria! Impact of World Cancer Day Walk on Health Behaviors Among Nigerians" will describe the sociodemographic and risk factor distribution of the Abuja, Nigeria "World Cancer Day Walk" participants according to their motive for participation, and secondarily, to investigate the impact of the event on educating attendees from the general population about cancer prevention and screening, in particular the importance of being physically active and maintaining a healthy body weight. Obesity is a known risk factor contributing to the development of cancer and NCD's.
The study will take place in Abuja, Nigeria on Feb 1, 2020 during the 6th Annual "World Cancer Day Walk" sponsored by Project PINK BLUE, a registered Nigerian nonprofit cancer organization, viz. Health \& Psychological Trust Centre (CAC/IT/NO 73960).
The purpose of the "World Cancer Day Walk" is to create awareness and advocate for better cancer care for Nigerians. The event offers free breast, cervical, and prostate cancer screenings; heath education and information about cancer risk reduction; and group physical activities that include a 5km Walk, 10km Race, 20km Ride, 5km Skate, 50km Cycle, and Marathon.
On the day of the event, the in-field research team will distribute a voluntary, one-page questionnaire to the anticipated 3,000 event participants to ascertain demographic information, cancer risk factors, motivations for attending the event, and lifestyle behaviors. Subjects will be recruited voluntarily onsite during the event following inclusion and exclusion criteria. Informed consent will be taken.
The questionnaire is 27 questions. Part one (eight questions) captures basic demographic information. Part two (six questions) captures personal and family history of cancer and cancer screening. Part three (six questions) captures information about the motivation for attending the event (free screening vs. fun/activities) and preferred ways to receive healthy lifestyle and cancer risk reduction / prevention information. Part four (five questions) captures lifestyle behaviors. Part five is the validated seven question International Physical Activity Questionnaire (IPAQ) instrument that measures physical activity and reduced sedentary behavior over the last seven days.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
Participants having previously attended at least once in previous years the "World Cancer Day Walk" will be considered as the group exposed to the health education intervention (returning).
Healthy Lifestyle Education
Healthy lifestyle information (education) is distributed to participants during the "World Cancer Day Walk" via brochure, lectures, and professional counseling.
Control Group
The control/non-exposed group will be the participants who are attending the "World Cancer Day Walk" for the first time in 2020 (first timers) and have not yet received health education information.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Healthy Lifestyle Education
Healthy lifestyle information (education) is distributed to participants during the "World Cancer Day Walk" via brochure, lectures, and professional counseling.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing and able to converse and/or read and write in either English or Pidgin English.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Project PINKBLUE, Health and Psychological Trust Centre
UNKNOWN
University Of Nigeria Teaching Hospital
NETWORK
Vaughan A. Lewis Institute for Research and Innovation
OTHER
Columbia University
OTHER
AshtaYoga, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leigh Leibel, MSc
Role: PRINCIPAL_INVESTIGATOR
Columbia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Project Pink Blue
Abuja, , Nigeria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jemal A, Brawley OW. Increasing cancer awareness and prevention in Africa. Ecancermedicalscience. 2019 Jul 25;13:939. doi: 10.3332/ecancer.2019.939. eCollection 2019.
Jedy-Agba EE, Oga EA, Odutola M, Abdullahi YM, Popoola A, Achara P, Afolayan E, Banjo AA, Ekanem IO, Erinomo O, Ezeome E, Igbinoba F, Obiorah C, Ogunbiyi O, Omonisi A, Osime C, Ukah C, Osinubi P, Hassan R, Blattner W, Dakum P, Adebamowo CA. Developing National Cancer Registration in Developing Countries - Case Study of the Nigerian National System of Cancer Registries. Front Public Health. 2015 Jul 30;3:186. doi: 10.3389/fpubh.2015.00186. eCollection 2015.
Brawley OW. The role of government and regulation in cancer prevention. Lancet Oncol. 2017 Aug;18(8):e483-e493. doi: 10.1016/S1470-2045(17)30374-1. Epub 2017 Jul 26.
Rimer BK, Glassman B. Is there a use for tailored print communications in cancer risk communication? J Natl Cancer Inst Monogr. 1999;(25):140-8. doi: 10.1093/oxfordjournals.jncimonographs.a024190.
Brawley OW, Cowal SG. Civil society's role in efforts to control women's cancers. Lancet. 2017 Feb 25;389(10071):775-776. doi: 10.1016/S0140-6736(16)31799-8. Epub 2016 Nov 1. No abstract available.
Oyetunde MO. Perception and management of cancer among the Yoruba in Ibadan, Nigeria. Afr J Med Med Sci. 2010 Sep;39(3):181-92.
Chidebe RCW, Leibel LL, Orjiakor TC, Shrestha A, Agha AA, Altinok Dindar D, Kisakol B, Ipiankama SC, Okoye IJ, Mason M, Auguste A, Esiaka DK. Promoting cancer prevention through World Cancer Day in Nigeria. Lancet Oncol. 2023 Apr;24(4):319-322. doi: 10.1016/S1470-2045(22)00692-1. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Nigeria Cancer Walk
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.